SSH - JOHNSTOWN INC. — History
CCN 392031 | 3-year financial timeline | COVID resilience: 36/100
🛡️ Public data only — no PHI permitted on this instance.
$16M
Latest Revenue (FY2022)
+2.0%
Revenue CAGR (3yr)
13.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $17M | $16M | -8.5% | +2.0% |
| Operating Expenses | $12M | $13M | $14M | +9.7% | +8.2% |
| Operating Margin | 23.4% | 28.2% | 13.9% | -50.7% | -22.9% |
| Net Income | $4M | $5M | $2M | -54.9% | -21.3% |
| Licensed Beds | 39 | 39 | 39 | +0.0% | +0.0% |
| Total Patient Days | 8,592 | 9,141 | 9,060 | -0.9% | +2.7% |
| Medicare Day % | 52% | 48% | 54% | +11.7% | +2.0% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 36/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +4.1% ($15M → $16M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+2.0%
This Hospital
+7.6%
State Avg
Latest Margin
13.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $16M | 9.2% |
| FY2024 (proj) | $17M | 4.4% |
| FY2025 (proj) | $17M | -0.3% |